Tapewire

Nasdaq · USD

RNAC

Cartesian Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6015
SEC CIK
0001453687
Parsed reports
365

Last 12 months

Inside the activity.

1 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202510
Jan 202603
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 15, 2017 Filed Jun 19, 2017 20:12 UTC
Johnston Lloyd P.COO and SVP, R*D · 10% owner
Exercise / conversionCommon Stock 20,512 $0.47 $9,640.64
Disclosure

SEC source: 0001638599-17-000626 · doc4_4803.xml · nonDerivative · entry 1

Johnston Lloyd P. · CIK 0001676905 · COO and SVP, R*D · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,118

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 15, 2017 Filed Jul 10, 2017 20:19 UTC Amendment
Johnston Lloyd P.COO and SVP, R&D
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 10,512 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001638599-17-000690 · doc4a_4836.xml · derivative · entry 3

Johnston Lloyd P. · CIK 0001676905 · COO and SVP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,512 shares

Expires 2019-07-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 19, 2017, the reporting person filed a Form 4 reporting the June 15, 2017 exercise and sale of 20,512 shares of common stock pursuant to a 10b5-1 plan. The reporting person's broker subsequently acknowledged that 10,000 of such 20,512 shares were erroneously exercised and sold by the broker. The exercise and sale of the 10,000 shares was unwound through the broker's error account and therefore did not occur for purposes of the reporting person's account. This Form 4 amends and restates, in their entirety, the transactions reported in the June 19, 2017 Form 4.

F4 · derivative.exercise_date: All shares underlying this option are fully vested.

Read SEC document
June 15, 2017 Filed Jul 10, 2017 20:19 UTC Amendment
Johnston Lloyd P.COO and SVP, R&D
SaleCommon Stock 10,512 $17.04 $179,141.30
Disclosure

SEC source: 0001638599-17-000690 · doc4a_4836.xml · nonDerivative · entry 2

Johnston Lloyd P. · CIK 0001676905 · COO and SVP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,606

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.

F1 · shares: On June 19, 2017, the reporting person filed a Form 4 reporting the June 15, 2017 exercise and sale of 20,512 shares of common stock pursuant to a 10b5-1 plan. The reporting person's broker subsequently acknowledged that 10,000 of such 20,512 shares were erroneously exercised and sold by the broker. The exercise and sale of the 10,000 shares was unwound through the broker's error account and therefore did not occur for purposes of the reporting person's account. This Form 4 amends and restates, in their entirety, the transactions reported in the June 19, 2017 Form 4.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.96 to $17.10, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Read SEC document
June 15, 2017 Filed Jul 10, 2017 20:19 UTC Amendment
Johnston Lloyd P.COO and SVP, R&D
Exercise / conversionCommon Stock 10,512 $0.47 $4,940.64
Disclosure

SEC source: 0001638599-17-000690 · doc4a_4836.xml · nonDerivative · entry 1

Johnston Lloyd P. · CIK 0001676905 · COO and SVP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,118

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 19, 2017, the reporting person filed a Form 4 reporting the June 15, 2017 exercise and sale of 20,512 shares of common stock pursuant to a 10b5-1 plan. The reporting person's broker subsequently acknowledged that 10,000 of such 20,512 shares were erroneously exercised and sold by the broker. The exercise and sale of the 10,000 shares was unwound through the broker's error account and therefore did not occur for purposes of the reporting person's account. This Form 4 amends and restates, in their entirety, the transactions reported in the June 19, 2017 Form 4.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:05 UTC PurchaseCommon Stock 518 $13.75 $7,122.50
Disclosure

SEC source: 0001638599-17-000527 · doc4_4755.xml · nonDerivative · entry 1

SPRINGER TIMOTHY A · CIK 0001055624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,622

Read SEC document
May 18, 2017 Filed May 19, 2017 20:06 UTC PurchaseCommon Stock 4,860 $14.00 $68,040.00
Disclosure

SEC source: 0001144204-17-028639 · v467529_4.xml · nonDerivative · entry 2

SPRINGER TIMOTHY A · CIK 0001055624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,104

Read SEC document
May 17, 2017 Filed May 19, 2017 20:06 UTC PurchaseCommon Stock 11,244 $14.01 $157,483.46
Disclosure

SEC source: 0001144204-17-028639 · v467529_4.xml · nonDerivative · entry 1

SPRINGER TIMOTHY A · CIK 0001055624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,244

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.64 to $14.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 16, 2017 Filed May 16, 2017 21:28 UTC
Kania EdwinDirector
SaleCommon Stock 266,795 $14.00 $3,735,130.00
Disclosure

SEC source: 0001012975-17-000439 · edgar.xml · nonDerivative · entry 1

KANIA EDWIN M JR · CIK 0001255927 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 560,067

F1 · ownership.nature: Held by Flagship Ventures Fund 2007, L.P. ("Flagship 2007"). Flagship Ventures 2007 General Partner LLC ("Flagship 2007 LLC") is the general partner of Flagship 2007. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship 2007 LLC. Flagship 2007 LLC and each of these individuals may be deemed to share voting and investment power with respect to all shares held by Flagship 2007. Mr. Kania disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Read SEC document
April 17, 2017 Filed Apr 18, 2017 21:18 UTC
Johnston Lloyd P.COO AND SVP, R&D
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 13,205 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001104659-17-024214 · a4.xml · derivative · entry 3

Johnston Lloyd P. · CIK 0001676905 · COO AND SVP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,205 shares

Expires 2018-07-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: All shares underlying this option are fully vested.

Read SEC document
April 17, 2017 Filed Apr 18, 2017 21:18 UTC
Johnston Lloyd P.COO AND SVP, R&D
SaleCommon Stock 13,205 $13.95 $184,209.75
Disclosure

SEC source: 0001104659-17-024214 · a4.xml · nonDerivative · entry 2

Johnston Lloyd P. · CIK 0001676905 · COO AND SVP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,606

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.

Read SEC document
April 17, 2017 Filed Apr 18, 2017 21:18 UTC
Johnston Lloyd P.COO AND SVP, R&D
Exercise / conversionCommon Stock 13,205 $0.39 $5,149.95
Disclosure

SEC source: 0001104659-17-024214 · a4.xml · nonDerivative · entry 1

Johnston Lloyd P. · CIK 0001676905 · COO AND SVP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,811

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 20:02 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,492 $0.00 Strike: $11.00 $0.00
Disclosure

SEC source: 0001104659-17-021351 · a4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,328

Underlying: Common Stock · 2,492 shares

Expires 2026-07-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vests in thirty-six (36) substantially equal monthly installments over three years following the date of grant.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 20:02 UTC Exercise / conversionCommon Stock 2,492 $11.00 $27,412.00
Disclosure

SEC source: 0001104659-17-021351 · a4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,492

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 23, 2017 Filed Mar 27, 2017 20:02 UTC Exercise / conversionStock Option (right to buy) · Derivative 8,019 $0.00 Strike: $7.02 $0.00
Disclosure

SEC source: 0001104659-17-019393 · a4.xml · derivative · entry 6

Farokhzad Omid · CIK 0001586852 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,622

Underlying: Common Stock · 8,019 shares

Expires 2026-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option vests in 48 substantially equal monthly installments beginning on January 1, 2016.

Read SEC document
March 23, 2017 Filed Mar 27, 2017 20:02 UTC Exercise / conversionStock Option (right to buy) · Derivative 51,981 $0.00 Strike: $3.44 $0.00
Disclosure

SEC source: 0001104659-17-019393 · a4.xml · derivative · entry 5

Farokhzad Omid · CIK 0001586852 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,932

Underlying: Common Stock · 51,981 shares

Expires 2022-01-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All shares underlying this option are fully vested.

Read SEC document
March 23, 2017 Filed Mar 27, 2017 20:02 UTC Exercise / conversionCommon Stock 8,019 $7.02 $56,293.38
Disclosure

SEC source: 0001104659-17-019393 · a4.xml · nonDerivative · entry 2

Farokhzad Omid · CIK 0001586852 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,004

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 23, 2017 Filed Mar 27, 2017 20:02 UTC Exercise / conversionCommon Stock 51,981 $3.44 $178,814.64
Disclosure

SEC source: 0001104659-17-019393 · a4.xml · nonDerivative · entry 1

Farokhzad Omid · CIK 0001586852 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,985

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 23, 2017 Filed Jan 30, 2017 21:54 UTC
Johnston Lloyd P.COO AND SVP, R&D
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 15,000 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001104659-17-004977 · a4.xml · derivative · entry 4

Johnston Lloyd P. · CIK 0001676905 · COO AND SVP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,205

Underlying: Common Stock · 15,000 shares

Expires 2018-07-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All shares underlying this option are fully vested.

Read SEC document
January 23, 2017 Filed Jan 30, 2017 21:54 UTC
Johnston Lloyd P.COO AND SVP, R&D
SaleCommon Stock 3,890 $14.17 $55,121.30
Disclosure

SEC source: 0001104659-17-004977 · a4.xml · nonDerivative · entry 3

Johnston Lloyd P. · CIK 0001676905 · COO AND SVP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,606

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.01 to $15.00, inclusive.

Read SEC document
January 23, 2017 Filed Jan 30, 2017 21:54 UTC
Johnston Lloyd P.COO AND SVP, R&D
SaleCommon Stock 11,110 $13.95 $154,984.50
Disclosure

SEC source: 0001104659-17-004977 · a4.xml · nonDerivative · entry 2

Johnston Lloyd P. · CIK 0001676905 · COO AND SVP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,496

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.95 to $14.00, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) of this Form 4.

Read SEC document
January 23, 2017 Filed Jan 30, 2017 21:54 UTC
Johnston Lloyd P.COO AND SVP, R&D
Exercise / conversionCommon Stock 15,000 $0.39 $5,850.00
Disclosure

SEC source: 0001104659-17-004977 · a4.xml · nonDerivative · entry 1

Johnston Lloyd P. · CIK 0001676905 · COO AND SVP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,606

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 28, 2016 Filed Dec 30, 2016 23:07 UTC
Kishimoto Takashi KeiChief Scientific Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $2.77 $0.00
Disclosure

SEC source: 0001104659-16-164625 · a4.xml · derivative · entry 3

Kishimoto Takashi Kei · CIK 0001676930 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,743

Underlying: Common Stock · 10,000 shares

Expires 2021-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares underlying the option are fully vested.

Read SEC document
December 28, 2016 Filed Dec 30, 2016 23:07 UTC
Kishimoto Takashi KeiChief Scientific Officer
SaleCommon Stock 10,000 $17.55 $175,500.00
Disclosure

SEC source: 0001104659-16-164625 · a4.xml · nonDerivative · entry 2

Kishimoto Takashi Kei · CIK 0001676930 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
December 28, 2016 Filed Dec 30, 2016 23:07 UTC
Kishimoto Takashi KeiChief Scientific Officer
Exercise / conversionCommon Stock 10,000 $2.77 $27,700.00
Disclosure

SEC source: 0001104659-16-164625 · a4.xml · nonDerivative · entry 1

Kishimoto Takashi Kei · CIK 0001676930 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 21, 2016 Filed Dec 23, 2016 19:19 UTC
Abraham DavidCCO, Gen.Counsel, Corp.Sec.
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 12,280 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001104659-16-163717 · a4.xml · derivative · entry 3

Abraham David · CIK 0001676903 · CCO, Gen.Counsel, Corp.Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 540

Underlying: Common Stock · 12,280 shares

Expires 2019-07-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These securities are fully vested.

Read SEC document
December 21, 2016 Filed Dec 23, 2016 19:19 UTC
Abraham DavidCCO, Gen.Counsel, Corp.Sec.
SaleCommon Stock 14,844 $18.00 $267,192.00
Disclosure

SEC source: 0001104659-16-163717 · a4.xml · nonDerivative · entry 2

Abraham David · CIK 0001676903 · CCO, Gen.Counsel, Corp.Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
December 21, 2016 Filed Dec 23, 2016 19:19 UTC
Abraham DavidCCO, Gen.Counsel, Corp.Sec.
Exercise / conversionCommon Stock 12,280 $0.47 $5,771.60
Disclosure

SEC source: 0001104659-16-163717 · a4.xml · nonDerivative · entry 1

Abraham David · CIK 0001676903 · CCO, Gen.Counsel, Corp.Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,844

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 19, 2016 Filed Dec 22, 2016 00:14 UTC
Keller PeterChief Business Officer
SaleCommon Stock 4,723 $18.58 $87,753.34
Disclosure

SEC source: 0001104659-16-163295 · a4.xml · nonDerivative · entry 1

Keller Peter · CIK 0001676904 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 405

F1 · balance_after: These shares are restricted common stock which are subject to a right of repurchase by the Issuer until December 31, 2016.

Read SEC document
July 29, 2016 Filed Apr 4, 2017 20:01 UTC Amendment GrantStock Option (Right to Buy) · Derivative 12,820 $0.00 Strike: $11.00 $0.00
Disclosure

SEC source: 0001104659-17-021348 · a4a.xml · derivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,820

Underlying: Common Stock · 12,820 shares

Expires 2026-07-28

F1 · derivative.exercise_price: The Form 4 filed on August 2, 2016 contained a Scrivener's error in the exercise price. This amendment has been filed solely to correct the exercise price of the July 29, 2016 grant from $10.99 to $11.00 per share.

F2 · derivative.exercise_date: The option vests in thirty-six (36) substantially equal monthly installments over three years following the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.